BP’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,008
Closed -$782K 545
2021
Q2
$782K Sell
5,008
-2,230
-31% -$361K 0.03% 289
2021
Q1
$1.13M Sell
7,238
-1,648
-19% -$255K 0.04% 267
2020
Q4
$1.33M Sell
8,886
-9,228
-51% -$1.3M 0.04% 262
2020
Q3
$2.39M Sell
18,114
-3,516
-16% -$459K 0.06% 251
2020
Q2
$2.51M Hold
21,630
0.09% 233
2020
Q1
$2.12M Hold
21,630
0.09% 221
2019
Q4
$3.14M Hold
21,630
0.11% 208
2019
Q3
$2.88M Buy
21,630
+1,030
+5% +$133K 0.11% 218
2019
Q2
$2.35M Sell
20,600
-3,090
-13% -$362K 0.09% 261
2019
Q1
$2.94M Hold
23,690
0.11% 211
2018
Q4
$2.38M Sell
23,690
-2,575
-10% -$290K 0.1% 226
2018
Q3
$3.35M Buy
+26,265
New +$3.12M 0.1% 214
2018
Q2
Sell
-24,720
Closed -$2.62M 523
2018
Q1
$2.62M Hold
24,720
0.1% 250
2017
Q4
$2.9M Hold
24,720
0.1% 236
2017
Q3
$2.81M Hold
24,720
0.1% 246
2017
Q2
$3.08M Hold
24,720
0.11% 229
2017
Q1
$2.93M Hold
24,720
0.11% 229
2016
Q4
$2.48M Sell
24,720
-11,330
-31% -$1.21M 0.09% 264
2016
Q3
$4.55M Hold
36,050
0.18% 158
2016
Q2
$4.21M Buy
36,050
+16,480
+84% +$1.87M 0.17% 167
2016
Q1
$2.02M Buy
+19,570
New +$1.89M 0.08% 256
2015
Q2
Sell
-25,750
Closed -$2.93M 302
2015
Q1
$2.93M Hold
25,750
0.09% 237
2014
Q4
$2.83M Buy
25,750
+5,150
+25% +$543K 0.07% 242
2014
Q3
$2.01M Hold
20,600
0.06% 259
2014
Q2
$2.08M Sell
20,600
-103,000
-83% -$10M 0.07% 241
2014
Q1
$11.4M Hold
123,600
0.38% 62
2013
Q4
$11.2M Buy
+123,600
New +$10.7M 0.41% 66

Other funds holding ZBH

BP's ZBH Position: Q3 2021 in Review

BP sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 5,008 shares — an estimated $782K sold.

BP first reported a position in ZBH in Q4 2013 and held it in 27 quarters. The position peaked at $11.4M in Q1 2014. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • BP reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • BP sold 5,008 Zimmer Biomet shares in Q3 2021, an estimated $782K.
  • BP first reported a position in Zimmer Biomet in Q4 2013 and held it in 27 quarters.
  • BP's Zimmer Biomet position peaked at $11.4M in Q1 2014.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.